Search

everythinglearnresearchcommunity

for

Search:↓

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

New oral treatment, finasteride, effectively and safely treats common hair loss.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Rosemary leaf extract may be an effective natural treatment for hair growth and male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride and dutasteride do not significantly change beard thickness in men.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Consider benefits and risks of new alopecia treatments for safety.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.